Journal of Cancer Research and Therapeutics

Journal Information
ISSN / EISSN : 0973-1482 / 1998-4138
Published by: Medknow (10.4103)
Total articles ≅ 3,903
Current Coverage
SCOPUS
LOCKSS
MEDICUS
MEDLINE
PUBMED
DOAJ
SCIE
Archived in
EBSCO
SHERPA/ROMEO
Filter:

Latest articles in this journal

Cihan Erol, MehmetAli Nahit Sendur, Irem Bilgetekin, DuyguBayir Garbioglu, Jamshid Hamdard, Sinem Akbas, Mutlu Hizal, Cagatay Arslan, Alper Sevinc, Ahmet Kucukarda, et al.
Published: 1 January 2022
Journal of cancer research and therapeutics; https://doi.org/10.4103/jcrt.jcrt_1104_21

Eiman Alseddeeqi, Ajda Altinoz, Abderrahim Oulhaj, Abubaker Suliman, Luaia Ahmed
Published: 1 January 2022
Journal of cancer research and therapeutics; https://doi.org/10.4103/jcrt.jcrt_999_21

Donghyun Kim, Jiho Nam, Dahl Park, Wontaek Kim
Published: 1 January 2022
Journal of cancer research and therapeutics; https://doi.org/10.4103/jcrt.jcrt_1394_21

Abstract:
Malignant glomus tumors of the head and neck are extremely rare, and to our knowledge, a response to high-dose radiation has not been described previously. We report one case in an 80-year-old woman with right nasal cavity mass. Histological examination revealed sheets of atypical round glomus cells. The presence of increased mitotic activity (25 per 10 high-power fields), cellular atypism, and tumor necrosis suggested malignancy. The smooth muscle actin, vimentin, and h-caldesmon immunohistochemistry stains the tumor cells. Two cycles of doxorubicin and cyclophosphamide chemotherapy were done and the tumor size was slightly increased. Salvage radiation therapy (RT) was delivered to the primary mass over 4 weeks (50 Gy in 20 fractions) and leading to nearly complete regression of tumor. Additional investigations are warranted so that we may determine the usefulness of RT in the management of this rare tumor.
Zhigang Wei, Xin Ye, Pikun Cao, Wenjun Meng, Guoliang Xue, Nan Wang, Zhichao Li, YongMei Kong
Published: 1 January 2022
Journal of cancer research and therapeutics; https://doi.org/10.4103/jcrt.jcrt_1286_21

Rajesh Kumar, Rajesh Pasricha, Manojkumar Gupta, Bina Ravi
Published: 1 January 2022
Journal of cancer research and therapeutics; https://doi.org/10.4103/jcrt.jcrt_672_21

Anusheel Munshi, JaiPrakash Agarwal, Kumar Prabhash
Published: 1 January 2022
Journal of cancer research and therapeutics; https://doi.org/10.4103/jcrt.jcrt_496_20

AnkitaRungta Kapoor, Manish Chandra, Rajendra Bhalavat, Chetna Bakshi, Chetan Anchan, Pratibha Bauskar, Saurabh Markana
Published: 1 January 2022
Journal of cancer research and therapeutics; https://doi.org/10.4103/jcrt.jcrt_680_20

Abstract:
Rhabdomyosarcomas (RMS) are pediatric soft-tissue sarcomas arising from immature mesenchymal cells that are intended to form striated skeletal muscles. Brachytherapy delivers high-dose of precised radiation to the target tissue with high conformity, sparing the nearby normal tissues, hence allowing dose escalation and reducing the likelihood of normal tissue toxicity. There is a scarcity of reports on the use of brachytherapy for extremity RMS. We report the case of pediatric extremity RMS treated with re-brachytherapy in recurrent setting. A 4-year-old boy diagnosed with RMS of right upper arm underwent local excision of the lesion. Postoperative magnetic resonance imaging showed suspicious residual lesion. Revision surgery followed by brachytherapy with 30 Gy in 10 fractions twice a day over 5 days was delivered. The child developed local recurrence after 12 months. Reexcision and re-irradiation with brachytherapy were done delivering 27 Gy in 9 fractions twice a day over 5 days. The child is disease-free 18 months posttreatment with no significant disparity in limb length suggestive of successful preservation of growth epiphysis. Re-irradiation with interstitial brachytherapy can be considered as an option for the treatment of recurrent pediatric extremity rhabdomyosarcoma, in conjunction with surgery and chemotherapy, despite treated previously with brachytherapy.
Ashwani Tandon, Garima Vijayvergiya, Hemlata Panwar, Tummidi Santosh, Vikas Gupta, Neelkamal Kapoor
Published: 1 January 2022
Journal of cancer research and therapeutics; https://doi.org/10.4103/jcrt.jcrt_1422_20

Abstract:
Mucoepidermoid carcinoma (MEC) is a rare malignant thyroid neoplasm. Cases of MEC with papillary, insular, and anaplastic thyroid carcinoma have been reported. Here, we present a case of follicular carcinoma with extensive MEC-like differentiation. A 62-year-old female presented with complaint of thyroid swelling for 10 years. Cytological features were suggestive of follicular neoplasm. Contrast-enhanced computed tomography showed metastasis to lung and vertebrae. Salivary glands and breasts were normal on examination and imaging. Subtotal thyroidectomy with bilateral neck dissection surgery was performed. The specimen was submitted for histopathological examination. Microscopy showed features of follicular carcinoma with capsular and vascular invasion along with an additional MEC-like morphology. Follicular carcinoma with extensive MEC-like differentiation is a rare observation. Since the tumor was sparing salivary glands and breasts, we considered it as mucoepidermoid differentiation over a collision tumor. However, immunohistochemistry and molecular analysis were the limitations.
Neha Singh, Sanjay Kumar, Santprakash Kataria, Shruti Kandoi, Meena Verma, Rajeev Sen
Published: 1 January 2022
Journal of cancer research and therapeutics; https://doi.org/10.4103/jcrt.jcrt_712_21

Back to Top Top